Actively Recruiting
Biomarkers for Ventilator-associated Pneumonia
Led by Region Skane · Updated on 2024-11-15
1000
Participants Needed
5
Research Sites
376 weeks
Total Duration
On this page
Sponsors
R
Region Skane
Lead Sponsor
L
Lund University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate different peptide biomarkers, variations in the microbiome and patterns in the bacterial transcriptome as prognostic or diagnostic biomarkers of VAP.
CONDITIONS
Official Title
Biomarkers for Ventilator-associated Pneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admission to an intensive care unit
- Intubation within last 24 hours
- Anticipated mechanical ventilation of at least 48 hours
- Age 18 years or older
You will not qualify if you...
- Fraction of inspired oxygen (FiO2) above 70% or positive end-expiratory pressure (PEEP) above 15
- Severe coagulopathy defined as spontaneous PK(INR) >1.8 or thrombocytes <50
- Ongoing lung infection at ICU admission
- Severely elevated or unstable intracranial pressure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Vestre Viken
Drammen, Norway, 3004
Actively Recruiting
2
Hospital de São Francisco Xavier
Lisbon, Portugal
Actively Recruiting
3
Skåne University Hospital, Dept. of Infectious diseases
Lund, Sweden
Actively Recruiting
4
Skåne university Hospital, ICU
Malmö, Sweden
Actively Recruiting
5
Karolinska University Hospital, ICU
Solna, Sweden
Not Yet Recruiting
Research Team
M
Magnus Paulsson, PhD MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here